New research article
A new research article resulting from a collaboration between the Institut de Cancérologie de Lorraine, bladder cancer company Photocure and ETAP-Lab was recently published in the journal Biomedicines: “Antitumor Effect and Induced Immune Response Following Exposure of Hexaminolevulinate and Blue Light in Combination with Checkpoint Inhibitor in an Orthotopic Model of Rat Bladder Cancer”
>> Article
This article reports on the effectiveness of a new therapy for the treatment of bladder cancer. By means of longitudinal follow-up over a period of up to 30 days, and supported by histology and immunohistochemistry results, the findings highlight the effectiveness of the combination of photodynamic therapy and a checkpoint inhibitor.
>> For more details: Photocure Press Release
We’d like to take this opportunity to congratulate all the authors for their work.
Contact Us
